PK/PD-integrated Bayesian platform design for phase II dose regimen optimization

Axel Vuorinen, Antoine Guillon, Emmanuelle Comets +2

Early-phase dose-finding methods increasingly assess toxicity and efficacy jointly, but comparisons based only on administered dose may inadequately characterize regimens differing…